{"id":"NCT01048788","sponsor":"Otsuka Pharmaceutical Co., Ltd.","briefTitle":"A Trial of OPC-41061 in Patients With Hepatic Edema - Investigation of the Safety of Treatment at 7.5 mg Beyond 7 Days and of the Effect of Dose Escalation to 15 mg","officialTitle":"A Multicenter, Uncontrolled, Open-label Phase 3 Trial of OPC-41061 in Patients With Hepatic Edema - Investigation of the Safety of Treatment at 7.5 mg Beyond 7 Days and of the Effect of Dose Escalation to 15 mg","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-12","primaryCompletion":"2011-08","completion":"2011-08","firstPosted":"2010-01-14","resultsPosted":"2014-03-04","lastUpdate":"2016-04-11"},"enrollment":51,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Cirrhosis"],"interventions":[{"type":"DRUG","name":"OPC-41061","otherNames":[]}],"arms":[{"label":"OPC","type":"EXPERIMENTAL"}],"summary":"OPC-41061 will be orally administered at 7.5 mg/day for 7 days to cirrhosis patients with ascites despite having received conventional diuretic therapy. Based on the change in body weight, on Day 7 it will be decided whether to continue administration at the same dose or to increase the dose, and then OPC-41061 will be orally administered for an additional 7 days at either 7.5 mg/day or, if diuretic effect for the initial 7-day administration is insufficient, at an increased dose of 15 mg/day. Plasma drug level, efficacy, and safety of OPC-41061 by 14-day repeated administration will be investigated.","primaryOutcome":{"measure":"Body Weight","timeFrame":"Baseline, Day 14 or end of administration","effectByArm":[{"arm":"Discontitued/Terminated Before Day 8","deltaMin":-0.76,"sd":0.93},{"arm":"Continued Administration at 7.5 mg/Day","deltaMin":-2.97,"sd":2.57},{"arm":"Dose Escalation to 15 mg/Day","deltaMin":-0.05,"sd":2.3}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":20},"locations":{"siteCount":6,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":8},"commonTop":["Thirst","Pyrexia","Insomnia","Constipation","Blood Pressure Decreased"]}}